Our team specializes in conducting bioavailability and bioequivalence studies, offering a comprehensive range of services that help pharmaceutical, biotechnology, and generic drug companies optimize their formulations and meet regulatory requirements. Our expertise ensures that study designs adhere to safety, efficacy, and regulatory standards, accelerating the path to market.

GenBiosis conducts bioavailability and bioequivalence studies in the following areas:

• Fasting, Fed, and Food-Effect Studies

• Parallel, Crossover, Partial Replicate, and Full Replicate Designs
• Long Housing Studies
• Long-Duration Studies with Ambulatory Sampling
• Proof-of-Concept Studies
• Special Population Studies
• Multiple Dose Studies
• Phase I Studies

We also conduct bioavailability and bioequivalence studies with various dosage forms, including:

Injection: Intramuscular, Intravenous, Subcutaneous

Tablets: Immediate Release, Extended Release, Sustained Release, Modified Release, Delayed Release, Orally Disintegrating Tablets (ODT), Chewable

Capsules: Extended Release, Modified Release, Delayed Release, Soft Gelatin

Other Forms: Suspensions, Solutions, Granules – Sublingual Preparations

With our expertise, we are committed to helping you navigate the complexities of drug development and regulatory compliance.